Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BELYS.BRthis companyBelysse Group N.V.	€0.35	-4.56×	0.4×	0.12×	4.47×	789.3%	26.6%	5.9%	-2.6%	-8.9%	6.2%	32.2%	2.12×	3.6×	0.76×	1.62×	0.0%	2	0.19	2	B-
DECB.BRDeceuninck N.V.	€2.41	13.35×	0.93×	0.41×	3.85×	118.9%	33.7%	7.7%	3.1%	7.1%	7.3%	8.3%	0.37×	0.91×	7.6×	1.56×	3.5%	6	2.63	4	A
HYL.BRHyloris Pharmaceuticals S.A.	€4.25	-29.74×	7.11×	26.14×	-20.46×	-236.5%	82.0%	-129.5%	-87.9%	-23.9%	-30.8%	-3.5%	0.06×	1.4×	-12.63×	3.89×	0.0%	2	8.47	1	D+
JEN.BRJensen-Group N.V.	€75.40	9.39×	1.82×	1.02×	7.66×	183.4%	42.9%	12.1%	10.9%	19.3%	13.1%	10.3%	0.22×	0.51×	12.17×	1.94×	1.7%	5	3.92	4	A+
Peer median	—	9.39×	1.82×	1.02×	3.85×	118.9%	42.9%	7.7%	3.1%	7.1%	7.3%	8.3%	0.22×	0.91×	7.6×	1.94×	1.7%	5	3.92	4	—